Coronavirus Update: AbbVie Jumps Into Antiviral Research With Scripps Pact
AbbVie is taking the plunge into the highly competitive area of antiviral research through a new alliance, while Pfizer files for US approval of an additional mRNA booster shot and a vaccines group is unhappy about planned IP waivers.